| 1 |
34053427 | Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells. | 2022 |
1 |
| 2 |
35205642 | Activation of ABCC Genes by Cisplatin Depends on the CoREST Occurrence at Their Promoters in A549 and MDA-MB-231 Cell Lines. | 2022 Feb 11 |
5 |
| 3 |
33205540 | m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation. | 2021 Jan |
1 |
| 4 |
33325136 | Cisplatin-resistant osteosarcoma cell-derived exosomes confer cisplatin resistance to recipient cells in an exosomal circ_103801-dependent manner. | 2021 Apr |
1 |
| 5 |
33570734 | Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis. | 2021 Jun |
2 |
| 6 |
33649818 | LRPPRC contributes to the cisplatin resistance of lung cancer cells by regulating MDR1 expression. | 2021 Apr |
1 |
| 7 |
34339285 | Circular RNAcirc_0076305 Promotes Cisplatin (DDP) Resistance of Non-Small Cell Lung Cancer Cells by Regulating ABCC1 Through miR-186-5p. | 2021 Aug 2 |
1 |
| 8 |
34522245 | Downregulation of long non-coding RNA B-Raf proto-oncogene-activated non-coding RNA reverses cisplatin resistance in laryngeal squamous cell carcinoma. | 2021 |
1 |
| 9 |
34523261 | Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis. | 2021 Nov |
1 |
| 10 |
34747666 | MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A. | 2021 Jan-Dec |
1 |
| 11 |
31986409 | CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis. | 2020 Apr |
1 |
| 12 |
32446175 | EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis. | 2020 Jul |
1 |
| 13 |
32523334 | Leonurine Promotes Cisplatin Sensitivity in Human Cervical Cancer Cells Through Increasing Apoptosis and Inhibiting Drug-Resistant Proteins. | 2020 |
2 |
| 14 |
32536824 | SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells. | 2020 |
1 |
| 15 |
33029084 | Metformin reverses the drug resistance of cisplatin in irradiated CNE-1 human nasopharyngeal carcinoma cells through PECAM-1 mediated MRPs down-regulation. | 2020 |
1 |
| 16 |
33123242 | Synergistic antitumor effect of dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with cisplatin on drug-resistant non-small cell lung cancer cell. | 2020 Dec |
1 |
| 17 |
31169018 | The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells. | 2019 Sep |
2 |
| 18 |
31173289 | LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis. | 2019 May |
1 |
| 19 |
31380278 | European mtDNA Variants Are Associated With Differential Responses to Cisplatin, an Anticancer Drug: Implications for Drug Resistance and Side Effects. | 2019 |
1 |
| 20 |
31579410 | The CK2 inhibitor CX4945 reverses cisplatin resistance in the A549/DDP human lung adenocarcinoma cell line. | 2019 Oct |
1 |
| 21 |
31659146 | Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p. | 2019 Oct 29 |
2 |
| 22 |
29548748 | Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway. | 2018 May 15 |
1 |
| 23 |
28075474 | Isomahanine induces endoplasmic reticulum stress and simultaneously triggers p38 MAPK-mediated apoptosis and autophagy in multidrug-resistant human oral squamous cell carcinoma cells. | 2017 Feb |
2 |
| 24 |
28443990 | MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma. | 2017 Apr 20 |
1 |
| 25 |
29299132 | Saikosaponins A, C and D enhance liver-targeting effects of anticancer drugs by modulating drug transporters. | 2017 Dec 15 |
2 |
| 26 |
26721606 | Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin. | 2016 Jan 22 |
2 |
| 27 |
26852750 | miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1. | 2016 Aug |
2 |
| 28 |
27284014 | Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation. | 2016 Jun 7 |
1 |
| 29 |
27485374 | Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation. | 2016 Aug 2 |
4 |
| 30 |
27906433 | MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1. | 2016 Nov |
2 |
| 31 |
25580427 | Emodin augments cisplatin cytotoxicity in platinum-resistant ovarian cancer cells via ROS-dependent MRP1 downregulation. | 2014 |
1 |
| 32 |
24103265 | [Effect of plasmid transfected shMRE11 on the drug-resistance of BEL7402/5-FU hepatoma cells]. | 2013 Oct |
1 |
| 33 |
21793937 | The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma. | 2012 Feb |
1 |
| 34 |
22941407 | Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1. | 2012 Nov |
1 |
| 35 |
21903448 | Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma. | 2011 Dec |
1 |
| 36 |
20005867 | Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin. | 2010 Apr 15 |
1 |
| 37 |
20458768 | Establishment of a human hepatoma multidrug resistant cell line in vitro. | 2010 May 14 |
1 |
| 38 |
20459793 | Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. | 2010 May 11 |
1 |
| 39 |
20628484 | Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line. | 2010 |
1 |
| 40 |
18695918 | In vitro susceptibility to anticancer agents of the human KB carcinoma cell line transfected with COX-2 cDNA. | 2008 Sep |
1 |
| 41 |
15517878 | Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15. | 2004 Sep-Oct |
1 |
| 42 |
16107775 | MDR1, MRP1 and MRP2 genotypes and in vitro chemosensitivity in Japanese patients with colorectal adenocarcinomas. | 2004 |
1 |
| 43 |
14671431 | The farnesyl protein transferase inhibitor lonafarnib (SCH66336) is an inhibitor of multidrug resistance proteins 1 and 2. | 2003 Dec |
1 |
| 44 |
12079522 | Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary. | 2002 Jun |
1 |
| 45 |
11259628 | Modulation of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms. | 2001 Apr |
5 |
| 46 |
11500053 | Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression. | 2001 Aug 17 |
1 |
| 47 |
10699972 | Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake. | 2000 Apr |
4 |
| 48 |
10944550 | A family of drug transporters: the multidrug resistance-associated proteins. | 2000 Aug 16 |
1 |
| 49 |
10100721 | Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. | 1999 Mar |
1 |
| 50 |
10363583 | Differences in substrate specificity among glutathione conjugates (GS-X) pump family members: comparison between multidrug resistance-associated protein and a novel transporter expressed on a cisplatin-resistant cell line (KCP-4). | 1999 Apr |
1 |